Medicare Advantage / payer cohorts
The bathroom as preventive infrastructure inside payer cohorts where outcomes drive economics.
Nitrites (urine)
Bacterial reduction of urinary nitrate. Specific marker for gram-negative bacteriuria.
Gait velocity
Walking speed across the room. Frailty, sarcopenia, and falls-risk signal.
ECG rhythm
P, QRS, T waveforms. Arrhythmia, conduction, and ischaemia screening.
Weight & body comp
Daily mass, fluid retention proxy, and trend signal for CHF, metabolic, and recovery.
Urinalysis test strip
10-parameter reagent strip read at the seat. Captures pH, nitrites, leukocytes, glucose, blood, protein, ketones, urobilinogen, bilirubin, and specific gravity from each void.
Urine spectroscopy (optical / SERS)
Non-contact optical analysis of urine in the bowl or stream. Uses vis-NIR absorbance, fluorescence, and surface-enhanced Raman spectroscopy (SERS) to fingerprint analytes without consumables. Calibrates against the same biochemistry strips read by urinalysis.
Load cell array
Strain-gauge load cells in the floor mat and seat for weight, weight distribution, balance, gait timing, and sit-to-stand dynamics.
Inertial sensors
Accelerometer and gyroscope arrays for body sway during standing, gait acceleration profile, and falls detection in the room.
ECG electrodes
Contact electrodes integrated into the seat for short-arm and short-leg ECG. Captures rhythm, conduction, and waveform morphology each sit.
- 01
How might we wire bathroom signal into payer outcome and risk programs?
- 02
How might we measure prevention in months and years, not single events?
- 03
How might we keep payer access cohort-level, not individual-level, by default?
Anchor in formation